This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Liisa Bayko
Managing Director, USA at Evercore ISI


Liisa Bayko is a Managing Director and Research Analyst at Evercore ISI covering small and mid-cap biotechnology companies. Ms. Bayko has over two decades of experience, beginning her career in strategy at Pharmacia in 1997 as an analyst in the strategy development group. In 2002 she joined Baker Brothers where she focused on assessing investment in emerging biopharmaceutical companies. She transitioned to the sell side in 2004 at Prudential covering biotech as an associate analyst. For the past 13 years, Liisa has been the senior biotech analyst at JMP Securities, focused on areas including rare diseases, NASH, gene therapy, food allergy, HBV, pulmonology and autoimmune. Ms. Bayko received her BS from Queen’s University in Life Science, Masters in Biophysics (Cancer Biology) from University of Toronto and her MBA from Northwestern.

Agenda Sessions

  • Panel Discussion: Investment View on Innovation in Cell & Gene Therapy: Trends, Technologies, and Early-Stage Success